Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05715255 · ClinicalTrials.gov registry record · NA
Adaptive Symptom Self-Management Immunotherapy Study
A NA study of Breast Cancer and Lung Cancer, sponsored by University of Arizona.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 3
- Study locations
NCT05715255 is a NA study of Breast Cancer and Lung Cancer that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 400 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05715255, a NA study of Breast Cancer and Lung Cancer, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 3
- Study locations
Study Summary
The use of immune checkpoint inhibitors (ICIs), alone or in combination with other cancer treatments is increasing dramatically with immune-related adverse events (irAEs) common (90%) during ICI treatment. Most irAEs are symptomatic and symptom self-management with timely reporting of moderate or severe symptoms to health care providers (HCPs) may reduce irAE severity by early recognition and management, resulting in fewer treatment interruptions and unscheduled health services.
Conditions Studied
Interventions
- BEHAVIORAL Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C)
- BEHAVIORAL Active control comparator
Study Locations (3)
Arizona
- Valleywise Health Medical Center - Phoenix
- University of Arizona Cancer Center - Tucson
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-05-08 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05715255
The ClinicalTrials.gov registry entry for NCT05715255 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C) is the first listed.
NCT05715255 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Michigan.
Frequently Asked Questions
What is clinical trial NCT05715255 about?
NCT05715255 is a clinical study titled "Adaptive Symptom Self-Management Immunotherapy Study". The use of immune checkpoint inhibitors (ICIs), alone or in combination with other cancer treatments is increasing dramatically with immune-related adverse events (irAEs) common (90%) during ICI treatment. Most irAEs are symptomatic and symptom self-management with timely reporting of moderate or se...
What is the current status of trial NCT05715255?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-05-08. Estimated completion is 2027-04-30.
What conditions does trial NCT05715255 study?
This clinical trial studies the following conditions: Breast Cancer, Lung Cancer, Colon Cancer, Skin Cancer, Rectum Cancer.
What interventions are being tested in trial NCT05715255?
The interventions under investigation include: Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C) (BEHAVIORAL), Active control comparator (BEHAVIORAL).
Who is sponsoring clinical trial NCT05715255?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05715255 being conducted?
This trial has 3 study locations across Arizona, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.